Contents

Current Cancer Drug Targets, Volume 9 - Number 1

Targeting ERBB Receptors to Inhibit Metastasis: Old Hopes and New Certainties

, 9(1): 1 - 18

Adriano Angelucci


DOI: 10.2174/156800909787314048




Emerging Treatments in Acute Lymphoblastic Leukemia

, 9(1): 19 - 31

R. Crazzolara and L. Bendall


DOI: 10.2174/156800909787314057




The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy

, 9(1): 32 - 71

Salvatore Ulisse, Enke Baldini, Salvatore Sorrenti and Massimino D'Armiento


DOI: 10.2174/156800909787314002




The Role of Downstream Signaling Pathways of the Epidermal Growth Factor Receptor for Artesunates Activity in Cancer Cells

, 9(1): 72 - 80

V. Badireenath Konkimalla, James A. McCubrey and Thomas Efferth


DOI: 10.2174/156800909787314020




TNF-α Induction by Nickel Compounds is Specific Through ERKs/AP-1- Dependent Pathway in Human Bronchial Epithelial Cells

, 9(1): 81 - 90

Jin Ding, Yi Huang, Beifang Ning, Wenfeng Gong, Jingxia Li, Hongyang Wang, Chang-Yan Chen and Chuanshu Huang


DOI: 10.2174/156800909787313995




The Changing Face of HDAC Inhibitor Depsipeptide

, 9(1): 91 - 100

Wen Zhou and Wei-Guo Zhu


DOI: 10.2174/156800909787314039




Fanconi Anemia Proteins, DNA Interstrand Crosslink Repair Pathways, and Cancer Therapy

, 9(1): 101 - 117

Paul R. Andreassen and Keqin Ren


DOI: 10.2174/156800909787314011




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science